Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
Sigyn Therapeutics's gross margin for the twelve months ending Sep 30, 2020 was 63.4%. For fiscal 2019 it was 75.1%, against 65.7% the year before. The highest annual figure on record is 75.1% in fiscal 2019.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 75.1% | +9.4 |
| FY2018 | Dec 31, 2018 | 65.7% | +21.5 |
| FY2017 | Dec 31, 2017 | 44.2% | −21.8 |
| FY2015 | Dec 31, 2015 | 66.0% | +24.5 |
| FY2014 | Dec 31, 2014 | 41.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | 53.1% | −20.8 |
| Q1 FY2020 | Mar 31, 2020 | 65.2% | −12.5 |
| Q4 FY2019 | Dec 31, 2019 | 70.5% | −15.5 |
| Q3 FY2019 | Sep 30, 2019 | 75.0% | −25.0 |
| Q2 FY2019 | Jun 30, 2019 | 73.8% | +15.7 |
| Q1 FY2019 | Mar 31, 2019 | 77.7% | +16.2 |
| Q3 FY2018 | Sep 30, 2018 | 86.0% | +28.8 |
| Q2 FY2018 | Jun 30, 2018 | 100.0% | +28.3 |
| Q1 FY2018 | Mar 31, 2018 | 58.2% | – |
| Q3 FY2017 | Sep 30, 2017 | 61.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 57.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 71.7% | – |
See a number that looks wrong?